Dr. Hugh Akston
Hedge fund manager, long/short equity, value

Invacare Dramatically Undervalued Due To Temporary FDA Issue

Invacare Corp. (NYSE:IVC) declined substantially following its Q2 2014 earnings report despite the fact that revenue actually came in higher than analyst expectations. We believe Mr. Market is being incredibly short-sighted on IVC and we believe the stock offers a tremendous risk/reward opportunity for those investors ...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.